Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Fair Value Measurements

v3.22.0.1
Fair Value Measurements
12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. A fair value hierarchy has been established based on three levels of inputs, of which the first two are considered observable and the last unobservable.
Level 1: Quoted prices in active markets for identical assets or liabilities. These are typically obtained from real-time quotes for transactions in active exchange markets involving identical assets.
Level 2: Inputs, other than quoted prices included within Level 1, which are observable for the asset or liability, either directly or indirectly. These are typically obtained from readily-available pricing sources for comparable instruments.
Level 3: Unobservable inputs, where there is little or no market activity for the asset or liability. These inputs reflect the reporting entity’s own assumptions of the data that market participants would use in pricing the asset or liability, based on the best information available in the circumstances.
Assets and Liabilities that are Measured at Fair Value on a Recurring Basis
The Company measures certain financial assets at fair value on a recurring basis, including its marketable securities and certain cash equivalents. The Company considers all securities available-for-sale, including those with maturity dates beyond 12 months, and therefore these securities are classified within current assets on the Consolidated Balance Sheets as they are available to support current operational liquidity needs. The money market accounts are valued based on quoted market prices in active markets. The marketable securities are generally valued based on other observable inputs for those securities (including market corroborated pricing or other models that utilize observable inputs such as interest rates and yield curves) based on information provided by independent third-party pricing entities, except for U.S. Treasury securities which are valued based on quoted market prices in active markets.
The following tables set forth the amortized cost, gross unrealized gains, gross unrealized losses, and fair values of the Company’s marketable securities accounted for as available-for-sale securities as of December 31, 2021 and 2020 (in thousands):
December 31, 2021
Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value
Financial Assets:
Short-term marketable securities:
     U.S. Treasury securities $ 52,791  $ 11  $ (138) $ 52,664 
Yankee bonds 6,175  (16) 6,160 
Agency bonds 17,546  —  (16) 17,530 
Municipal bonds 12,440  —  (211) 12,229 
     Commercial paper 17,694  —  (4) 17,690 
     Asset-backed securities 27,620  (86) 27,535 
     Corporate bonds 65,198  (452) 64,755 
Total $ 199,464  $ 22  $ (923) $ 198,563 
December 31, 2020
Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value
Financial Assets:
Short-term marketable securities:
     U.S. Treasury securities $ 21,357  $ $ (18) $ 21,340 
     Commercial paper 14,543  —  —  14,543 
     Asset-backed securities 14,546  —  (8) 14,538 
     Corporate bonds 17,144  —  (19) 17,125 
Total $ 67,590  $ $ (45) $ 67,546 
The Company had $0.6 million and $0.2 million of accrued interest receivable at December 31, 2021 and 2020, respectively, included in other assets on its Consolidated Balance Sheets related to its marketable securities. The amounts of realized gains and realized losses were immaterial for the years ended December 31, 2021 and 2020. There were no such amounts for the year ended December 31, 2019.
The following tables set forth the fair value of available-for-sale marketable securities by contractual maturity at December 31, 2021 and 2020 (in thousands):
December 31, 2021
One Year or Less Over One Year Through Five Years Over Five Years Total
Financial Assets:
Marketable Securities:
     U.S. Treasury securities $ 22,550  $ 30,114  $ —  $ 52,664 
Yankee bonds 4,150  2,010  —  6,160 
Agency bonds 14,041  3,489  —  17,530 
Municipal bonds —  12,229  —  12,229 
     Commercial paper 17,690  —  —  17,690 
     Asset-backed securities 20,868  6,667  —  27,535 
     Corporate bonds 25,412  39,343  —  64,755 
Total $ 104,711  $ 93,852  $ —  $ 198,563 
December 31, 2020
One Year or Less Over One Year Through Five Years Over Five Years Total
Financial Assets:
Marketable Securities:
     U.S. Treasury securities $ 6,075  $ 15,265  $ —  $ 21,340 
     Commercial paper 14,543  —  —  14,543 
     Asset-backed securities 560  13,978  —  14,538 
     Corporate bonds 5,863  11,262  —  17,125 
Total $ 27,041  $ 40,505  $ —  $ 67,546 
The following tables set forth the Company’s cash equivalents and marketable securities accounted for as available-for-sale securities that were measured at fair value on a recurring basis based on the fair value hierarchy as of December 31, 2021 and 2020 (in thousands):
December 31, 2021
Level 1 Level 2 Level 3 Total
Financial Assets:
Cash equivalents:
     Money market funds $ 254,157  $ —  $ —  $ 254,157 
     Commercial paper —  22,491  —  22,491 
Marketable securities:
     U.S. Treasury securities 52,664  —  —  52,664 
Yankee bonds 6,160  —  —  6,160 
Agency bonds 17,530  —  —  17,530 
Municipal bonds 12,229  —  —  12,229 
     Commercial paper —  17,690  —  17,690 
     Asset-backed securities —  27,535  —  27,535 
     Corporate bonds —  64,755  —  64,755 
Total $ 342,740  $ 132,471  $ —  $ 475,211 
December 31, 2020
Level 1 Level 2 Level 3 Total
Financial Assets:
Cash equivalents:
     Money market funds $ 209,141  $ —  $ —  $ 209,141 
     U.S. Treasury securities 1,000  —  —  1,000 
     Commercial paper —  3,999  —  3,999 
Marketable securities:
     U.S. Treasury securities 21,340  —  —  21,340 
     Commercial paper —  14,543  —  14,543 
     Asset-backed securities —  14,538  —  14,538 
     Corporate bonds —  17,125  —  17,125 
Total $ 231,481  $ 50,205  $ —  $ 281,686 
There were no transfers of financial assets or liabilities into or out of Level 1, Level 2, or Level 3 for the years ended December 31, 2021 and 2020.
Assets and Liabilities that are Measured at Fair Value on a Nonrecurring Basis
The carrying value of cash, certain cash equivalents, accounts receivable, net, other current assets, accounts payable, accrued expenses and other liabilities, and Pharma contract liabilities are considered reasonable estimates of their respective fair values at December 31, 2021 and 2020 due to their short-term nature.
The Company also measures certain non-financial assets at fair value on a nonrecurring basis, primarily intangible assets, goodwill, long-lived assets in connection with periodic evaluations for potential impairment. The Company estimates the fair value of these assets using primarily unobservable inputs and as such, these are considered Level 3 fair value measurements.